A new method for diagnosing antibodies to the enterovirus Echovirus 30 has been developed

08  11.2025 Specialists from the Nizhny Novgorod Research Institute of Epidemiology and Microbiology named after Academician I.N. Blokhina of Rospotrebnadzor have developed and received a patent for the invention "A method for detecting antibodies to recombinant proteins VP1, VP2, and VP3 of Echovirus 30."

Enteroviruses, particularly Echovirus 30, can cause a variety of human diseases. Symptoms range from a mild cold to more serious infections. The detection of antibodies to enteroviruses in human blood indicates a previous illness and the presence of immunity.

Specialists from the I.N. Blokhina Nizhny Novgorod Research Institute of Epidemiology and Microbiology (Rospotrebnadzor) have developed a new method for detecting antibodies to Echovirus 30 in human blood. The new method is based on the use of recombinant viral proteins VP1, VP2, and VP3, which interact with Echovirus 30-specific antibodies.

This new development has been used to assess individual and population immunity to Echovirus 30, as well as to test the effectiveness of vaccines against the virus.